Figure 2.
Figure 2. Inhibition of invariant chain synthesis enhances MHC class II presentation of OVA by DCs transfected with OVA mRNA. DCs were transfected with OVA mRNA or a truncated OVA mRNA (tOVA) from which sequences corresponding to the first 40 aa's of the OVA protein were deleted. As indicated, the OVA mRNA-transfected DCs were also treated with Ii AS (AE40) or control (SE40) ODNs. Presentation of the dominant MHC class II (A) and class I (B) OVA epitopes was determined by measuring IL-2 secretion from OVA class II and class I T-hybridomas, respectively.38 Measurements were done in triplicates. Variability is indicated by the error bars. Data are representative of 6 experiments using 2 Ii AS and control ODNs described in “Materials and methods.”

Inhibition of invariant chain synthesis enhances MHC class II presentation of OVA by DCs transfected with OVA mRNA. DCs were transfected with OVA mRNA or a truncated OVA mRNA (tOVA) from which sequences corresponding to the first 40 aa's of the OVA protein were deleted. As indicated, the OVA mRNA-transfected DCs were also treated with Ii AS (AE40) or control (SE40) ODNs. Presentation of the dominant MHC class II (A) and class I (B) OVA epitopes was determined by measuring IL-2 secretion from OVA class II and class I T-hybridomas, respectively.38  Measurements were done in triplicates. Variability is indicated by the error bars. Data are representative of 6 experiments using 2 Ii AS and control ODNs described in “Materials and methods.”

Close Modal

or Create an Account

Close Modal
Close Modal